| [1] |
Hellman S, Weichselbaum RR. Oligometastases[J]. J Clin Oncol，1995，13(1):8-10.
|
| [2] |
Paget S. The distribution of secondary growths in cancer of the breast. 1889[J]. Cancer Metastasis Rev，1989，8(2):98-101.
|
| [3] |
Gupta GP, Massagué J. Cancer metastasis：building a framework[J]. Cell，2006，127(4):679-695.
|
| [4] |
Fidler IJ. The organ microenvironment and cancer metastasis[J]. Differentiation，2002，70(9/10):498-505.
|
| [5] |
Lussier YA, Xing HR, Salama JK，et al. MicroRNA expression characterizes oligometastasis（es）[J]. PLoS One，2011，6(12):e28650.
|
| [6] |
Sharma S, Camci C, Jabbour N. Management of hepatic metastasis from colorectal cancers：an update[J]. J Hepatobiliary Pancreat Surg，2008，15(6):570-580.
|
| [7] |
Pulitanò C, Castillo F, Aldrighetti L，et al. What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up[J]. HPB（Oxford），2010，12(4):244-249.
|
| [8] |
Bergenfeldt M, Jensen BV, Skjoldbye B，et al. Liver resection and local ablation of breast cancer liver metastases：a systematic review[J]. Eur J Surg Oncol，2011，37(7):549-557.
|
| [9] |
Mariani P, Piperno-Neumann S, Servois V，et al. Surgical management of liver metastases from uveal melanoma：16 years' experience at the Institut Curie[J]. Eur J Surg Oncol，2009，35(11):1192-1197.
|
| [10] |
Mise Y, Kopetz S, Mehran RJ，et al. Is complete liver resection without resection of synchronous lung metastases justified?[J]. Ann Surg Oncol，2015，22(5):1585-1592.
|
| [11] |
Nordholm-Carstensen A, Krarup PM, Jorgensen LN，et al. Occurrence and survival of synchronous pulmonary metastases in colorectal cancer：a nationwide cohort study[J]. Eur J Cancer，2014，50(2):447-456.
|
| [12] |
Giuliante F, Ardito F, Ferrero A，et al. Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases：results of an Italian multicenter analysis of 130 patients[J]. J Am Coll Surg，2014，219(2):285-294.
|
| [13] |
Gruenberger T, Bridgewater J, Chau I，et al. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer：the OLIVIA multinational randomised phase II trial[J]. Ann Oncol，2015，26(4):702-708.
|
| [14] |
Gervais DA, Goldberg SN, Brown DB，et al. Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors[J]. J Vasc Interv Radiol，2009，20(7 Suppl):S342-S347.
|
| [15] |
Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours[J]. Cardiovasc Intervent Radiol，2010，33(1):11-17.
|
| [16] |
Wong SL, Mangu PB, Choti MA，et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer[J]. J Clin Oncol，2010，28(3):493-508.
|
| [17] |
Lee H, Heo JS, Cho YB，et al. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis：a propensity score analysis[J]. World J Gastroenterol，2015，21(11):3300-3307.
|
| [18] |
Li W, Bai YT, Wu M，et al. Combined CT-guided radiofrequency ablation with systemic chemotherapy improves the survival for nasopharyngeal carcinoma with oligometastasis in liver：Propensity score matching analysis[J]. Oncotarget，2017，8(32):52132-52141.
|
| [19] |
D'Angelica MI, Correa-Gallego C, Paty PB，et al. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer：conversion to resection and long-term outcomes[J]. Ann Surg，2015，261(2):353-360.
|
| [20] |
Vogl TJ, Gruber-Rouh T, Eichler K，et al. Repetitive transarterial chemoembolization（TACE）of liver metastases from gastric cancer：local control and survival results[J]. Eur J Radiol，2013，82(2):258-263.
|
| [21] |
Wu ZB, Si ZM, Qian S，et al. Percutaneous microwave ablation combined with synchronous transcatheter arterial chemoembolization for the treatment of colorectal liver metastases：results from a follow-up cohort[J]. Onco Targets Ther，2016，9:3783-3789.
|
| [22] |
Hashimoto Y, Sasaki Y, Yokoyama S，et al. A long-term survivor of a rectal carcinoid treated by use of repeat TACE for multiple intrahepatic recurrences after liver resection and MCT[J]. Gan To Kagaku Ryoho，2014，41(12):2142-2144.
|
| [23] |
Cruz JE, Saksena R, Jabbour SK，et al. The power of genes：a case of unusually severe systemic toxicity after localized hepatic chemoembolization with irinotecan-eluted microspheres for metastatic colon cancer[J]. Ann Pharmacother，2014，48(12):1646-1650.
|
| [24] |
De Souza A, Daly KP, Yoo J，et al. Safety and efficacy of combined yttrium 90 resin radioembolization with aflibercept and FOLFIRI in a patient with metastatic colorectal cancer[J]. Case Rep Oncol Med，2015，2015:461823.
|
| [25] |
Rusthoven KE, Kavanagh BD, Cardenes H，et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases[J]. J Clin Oncol，2009，27(10):1572-1578.
|
| [26] |
Shimada Y, Saji H, Kakihana M，et al. Survival outcomes for oligometastasis in resected non-small cell lung cancer[J]. Asian Cardiovasc Thorac Ann，2015，23(8):937-944.
|
| [27] |
Yamauchi Y, Izumi Y, Kawamura M，et al. Percutaneous cryoablation of pulmonary metastases from colorectal cancer[J]. PLoS One，2011，6(11):e27086. DOI： 10.1371/journal.pone.0027086. |
| [28] |
Okunieff P, Petersen AL, Philip A，et al. Stereotactic body radiation therapy（SBRT）for lung metastases[J]. Acta Oncol，2006，45(7):808-817.
|
| [29] |
Zheng QY, Zhang GH, Zhang Y，et al. Adrenalectomy May increase survival of patients with adrenal metastases[J]. Oncol Lett，2012，3(4):917-920.
|
| [30] |
Chawla S, Chen Y, Katz AW，et al. Stereotactic body radiotherapy for treatment of adrenal metastases[J]. Int J Radiat Oncol Biol Phys，2009，75(1):71-75.
|
| [31] |
Gunjur A, Duong C, Ball D，et al. Surgical and ablative therapies for the management of adrenal 'oligometastases'-A systematic review[J]. Cancer Treat Rev，2014，40(7):838-846.
|
| [32] |
Yao HH, Hong MKh, Corcoran NM，et al. Advances in local and ablative treatment of oligometastasis in prostate cancer[J]. Asia Pac J Clin Oncol，2014，10(4):308-321.
|
| [33] |
Choi D, Morris S, Crockard A，et al. Assessment of quality of life after surgery for spinal metastases：position statement of the global spine tumour study group[J]. World Neurosurg，2013，80(6):e175-e179.
|
| [34] |
Milano MT, Katz AW, Zhang H，et al. Oligometastases treated with stereotactic body radiotherapy：long-term follow-up of prospective study[J]. Int J Radiat Oncol Biol Phys，2012，83(3):878-886.
|
| [35] |
Takeda A, Kunieda E, Ohashi T，et al. Stereotactic body radiotherapy（SBRT）for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer[J]. Radiother Oncol，2011，101(2):255-259.
|
| [36] |
Norihisa Y, Nagata Y, Takayama K，et al. Stereotactic body radiotherapy for oligometastatic lung tumors[J]. Int J Radiat Oncol，2008，72(2):398-403.
|
| [37] |
Salama JK, Hasselle MD, Chmura SJ，et al. Stereotactic body radiotherapy for multisite extracranial oligometastases：final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease[J]. Cancer，2012，118(11):2962-2970.
|
| [38] |
Wersall PJ, Blomgren H, Lax I，et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma[J]. Radiother Oncol，2005，77(1):88-95.
|
| [39] |
Milano MT, Katz AW, Okunieff P. Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ[J]. Am J Clin Oncol，2010，33(2):157-163.
|
| [40] |
Milano MT, Katz AW, Muhs AG，et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions[J]. Cancer，2008，112(3):650-658.
|
| [41] |
Mole RH. Whole body irradiation; radiobiology or medicine?[J]. Br J Radiol，1953，26(305):234-241.
|